Fig. 5.
![Fig. 5. Comparison of APC resistance ratios for deglycosylated human and bovine factor V. Purified human (○, •) and bovine (▵, ▴) factor V were treated with neuraminidase and N-glycanase under conditions as in Fig 1 and then APC resistance ratios were determined after diluting factor V ([•, ▴] glycosidase-treated; [○, ▵] untreated controls) in factor V-deficient plasma using APTT assays.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/12/10.1182_blood.v89.12.4348/3/bl_0038f5.jpeg?Expires=1724133524&Signature=5AKoULvMYbSicro-E5lQU8Y2IkJqJ6xbrfoXUuF75Usky7ybdfM4xe0PKRl1tYi8GsiWvL5SyVI3f4eu973mjGbr7Z7wSZRhGTJgWhrrQJ3sjxwcj8y-eqiueI~Kqahpw0ukHn0FxQDOqdj19jantt1L8sRaLiNmOnZos85QbCwEfpQxG7z1B9l~XK3VAGVJRIq-eRUYSdcyyELw98riceZIntS~6Z1gE4qJ5~wm6HsR0Lr3-UV~yoBwgQ5L4lST7x-w0FzfCnMmM0-dKE~715RiQnGhfN2IMIN3eYBHTmt18G7MTwqG7Yyc10F7AzoqKmAjQ2ND2dtFae~Z-iDV7g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of APC resistance ratios for deglycosylated human and bovine factor V. Purified human (○, •) and bovine (▵, ▴) factor V were treated with neuraminidase and N-glycanase under conditions as in Fig 1 and then APC resistance ratios were determined after diluting factor V ([•, ▴] glycosidase-treated; [○, ▵] untreated controls) in factor V-deficient plasma using APTT assays.
